Cargando…

Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism

Viral pneumonia is widespread, progresses rapidly, and has a high mortality rate. Developing safe and effective therapies to treat viral pneumonia can minimize risks to public health and alleviate pressures on the associated health systems. Xiao-Chai-Hu (XCH) decoction can be used in the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng, Qu, Fei, Jia, Yuehui, Wang, Chengxin, Yu, Yuejie, Liao, Jiabao, Lin, Min, Chen, Fengjuan, Sun, Zhijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296287/
https://www.ncbi.nlm.nih.gov/pubmed/35865338
http://dx.doi.org/10.1155/2022/1240242
_version_ 1784750239098339328
author Chen, Feng
Qu, Fei
Jia, Yuehui
Wang, Chengxin
Yu, Yuejie
Liao, Jiabao
Lin, Min
Chen, Fengjuan
Sun, Zhijia
author_facet Chen, Feng
Qu, Fei
Jia, Yuehui
Wang, Chengxin
Yu, Yuejie
Liao, Jiabao
Lin, Min
Chen, Fengjuan
Sun, Zhijia
author_sort Chen, Feng
collection PubMed
description Viral pneumonia is widespread, progresses rapidly, and has a high mortality rate. Developing safe and effective therapies to treat viral pneumonia can minimize risks to public health and alleviate pressures on the associated health systems. Xiao-Chai-Hu (XCH) decoction can be used in the treatment of viral pneumonia. However, the mechanisms of XCH on viral pneumonia remain unclear. In this study, poly (I:C) was used to establish a mouse model of viral pneumonia, and the therapeutic effects of XCH on viral pneumonia were assessed. Furthermore, we evaluated the effects of XCH on inflammatory response. Lastly, untargeted metabolomics were used to study the metabolic regulatory mechanisms of XCH on viral pneumonia model mice. Our results showed that XCH treatment decreased the wet/dry ratio in lung tissue, total protein concentration, and total cell count in bronchoalveolar lavage fluid (BALF). H&E staining indicated that XCH treatment alleviated the pathological changes in lung. Moreover, XCH treatment decreased the levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and lowered the ratio of CD86(+)/CD206(+) macrophages and CD11b(+)LY6G(+) neutrophils in BALF. XCH treatment also decreased the myeloperoxidase (MPO) and reduced the phosphorylations of PI3K, AKT, and NF-κB p65 in lung. Serum untargeted metabolomics analysis showed that XCH treatment could affect 18 metabolites in serum such as creatine, hydroxyproline, cortisone, hydrocortisone, corticosterone, hypotaurine, and taurine. These metabolites were associated with arginine and proline metabolism, steroid hormone biosynthesis, and taurine and hypotaurine metabolism processes. In conclusion, our study demonstrated that treatment with XCH can ameliorate viral pneumonia and reduce inflammatory response in viral pneumonia. The mechanism of action of XCH in the treatment of viral pneumonia may be associated with inhibiting the activation of PI3K/AKT/NF-κB signaling pathway in lung and regulating arginine and proline metabolism, steroid hormone biosynthesis, and taurine and hypotaurine metabolism in serum.
format Online
Article
Text
id pubmed-9296287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92962872022-07-20 Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism Chen, Feng Qu, Fei Jia, Yuehui Wang, Chengxin Yu, Yuejie Liao, Jiabao Lin, Min Chen, Fengjuan Sun, Zhijia Evid Based Complement Alternat Med Research Article Viral pneumonia is widespread, progresses rapidly, and has a high mortality rate. Developing safe and effective therapies to treat viral pneumonia can minimize risks to public health and alleviate pressures on the associated health systems. Xiao-Chai-Hu (XCH) decoction can be used in the treatment of viral pneumonia. However, the mechanisms of XCH on viral pneumonia remain unclear. In this study, poly (I:C) was used to establish a mouse model of viral pneumonia, and the therapeutic effects of XCH on viral pneumonia were assessed. Furthermore, we evaluated the effects of XCH on inflammatory response. Lastly, untargeted metabolomics were used to study the metabolic regulatory mechanisms of XCH on viral pneumonia model mice. Our results showed that XCH treatment decreased the wet/dry ratio in lung tissue, total protein concentration, and total cell count in bronchoalveolar lavage fluid (BALF). H&E staining indicated that XCH treatment alleviated the pathological changes in lung. Moreover, XCH treatment decreased the levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and lowered the ratio of CD86(+)/CD206(+) macrophages and CD11b(+)LY6G(+) neutrophils in BALF. XCH treatment also decreased the myeloperoxidase (MPO) and reduced the phosphorylations of PI3K, AKT, and NF-κB p65 in lung. Serum untargeted metabolomics analysis showed that XCH treatment could affect 18 metabolites in serum such as creatine, hydroxyproline, cortisone, hydrocortisone, corticosterone, hypotaurine, and taurine. These metabolites were associated with arginine and proline metabolism, steroid hormone biosynthesis, and taurine and hypotaurine metabolism processes. In conclusion, our study demonstrated that treatment with XCH can ameliorate viral pneumonia and reduce inflammatory response in viral pneumonia. The mechanism of action of XCH in the treatment of viral pneumonia may be associated with inhibiting the activation of PI3K/AKT/NF-κB signaling pathway in lung and regulating arginine and proline metabolism, steroid hormone biosynthesis, and taurine and hypotaurine metabolism in serum. Hindawi 2022-07-12 /pmc/articles/PMC9296287/ /pubmed/35865338 http://dx.doi.org/10.1155/2022/1240242 Text en Copyright © 2022 Feng Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Feng
Qu, Fei
Jia, Yuehui
Wang, Chengxin
Yu, Yuejie
Liao, Jiabao
Lin, Min
Chen, Fengjuan
Sun, Zhijia
Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title_full Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title_fullStr Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title_full_unstemmed Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title_short Xiao-Chai-Hu Decoction Ameliorates Poly (I:C)-Induced Viral Pneumonia through Inhibiting Inflammatory Response and Modulating Serum Metabolism
title_sort xiao-chai-hu decoction ameliorates poly (i:c)-induced viral pneumonia through inhibiting inflammatory response and modulating serum metabolism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296287/
https://www.ncbi.nlm.nih.gov/pubmed/35865338
http://dx.doi.org/10.1155/2022/1240242
work_keys_str_mv AT chenfeng xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT qufei xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT jiayuehui xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT wangchengxin xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT yuyuejie xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT liaojiabao xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT linmin xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT chenfengjuan xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism
AT sunzhijia xiaochaihudecoctionamelioratespolyicinducedviralpneumoniathroughinhibitinginflammatoryresponseandmodulatingserummetabolism